Latest filing published 03 Mar 2026 for AbbVie Inc., €1.6M. Read the official filing
Roopal Thakkar appears in our data through filings on AbbVie Inc. shares, published by SEC (Form 4). We count 13 filings; the first trade dates from 15 February 2024 and the latest from 27 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 3 March 2026, the filings show a share grant worth €1.6M in AbbVie Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations